PDGFR dysregulation contributes to multiple malignancies, including gastrointestinal stromal tumors (GIST), chronic myeloid leukemia (with BCR-ABL fusion activating PDGFR-associated pathways), and various solid tumors. The gene discussed is PDGFRB; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.